In the News

1857 News Items found
MSK investigators Michael Berger and David Solit.
Finding
A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.
Pictured: William Lee, Chris Sander & Nils Weinhold
In the Lab
In a study of patient tumor samples, researchers have found common mutations in parts of the genome that control gene regulation.
Cancer biologist Andrea Ventura
In the Lab
MSK scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement.
A student asks a question at last year’s "Major Trends” seminar.
Event
Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.
Pictured: Pseudomonas aeruginosa
In the Lab
MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.
DNA wrapped around histones
Decoder
What Is Epigenetics?
Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.
Three friends
Support
Memorial Sloan Kettering social workers Meredith Cammarata and Liz Blackler give advice to anyone who wants to offer support to someone they know with cancer.
Pictured: Ping Chi
In the Lab
Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.
Pictured: Scott Lowe
In the Lab
In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.
Pictured: Experimental Brain Tumor
In the Lab
Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.